SillaJen

Global oncolytic immunotherapeutic company.

Launch date

2003

Employees

Market cap

Net debt

KRW34.6b

Enterprise valuation

$386m (Public information from Jun 2024)

San Francisco California (HQ)

http://sillajen.com

https://www.linkedin.com/company/sillajen-biotherapeutics-inc

Deals in current and previous year:

Jennerex Biotherapeutics

Authorizing premium user...